Skip to content
healthcare.dev

Plasbumin

NDC 13533-692, Albumin (Human), solution, from GRIFOLS USA, LLC.

Product NDC
13533-692
Status
Listed
Labeler
GRIFOLS USA, LLC
Dosage form
SOLUTION
Route
INTRAVENOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA101138
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/13533-692 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALBUMIN HUMAN5 g/20mL

Pharmacologic classes

Human Serum Albumin [EPC]; Increased Intravascular Volume [PE]; Increased Oncotic Pressure [PE]; Osmotic Activity [MoA]; Serum Albumin [Chemical/Ingredient]

Package NDCNDC-11Package
13533-692-16135330692161 VIAL in 1 CARTON (13533-692-16) / 20 mL in 1 VIAL (13533-692-17)
13533-692-20135330692201 VIAL in 1 CARTON (13533-692-20) / 50 mL in 1 VIAL (13533-692-21)
13533-692-71135330692711 VIAL in 1 CARTON (13533-692-71) / 100 mL in 1 VIAL (13533-692-72)

Linked data

RxNorm, label and prices

Use it

Look up 13533-692 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/13533-692 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 13533-692. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.